英文别名 |
ODU3ZAZ94J;Zavegepant;Zavegepant [USAN];BDBM50436107;WHO 11512;1-Piperidinecarboxamide, 4-(1,2-dihydro-2-oxo-3-quinolinyl)-N-((1R)-1-((7-methyl-1H-indazol-5-yl)methyl)-2-(4-(1-methyl-4-piperidinyl)-1-piperazinyl)-2-oxoethyl)-;4-(1,2-Dihydro-2-oxo-3-quinolinyl)-N-((1R)-1-((7-methyl-1H-indazol-5-yl)methyl)-2-(4-(1-methyl-4-piperidinyl)-1-piperazinyl)-2-oxoethyl)-1-piperidinecarboxamide;N-[(2R)-3-(7-methyl-1H;BMS-742413-01;Zavegepant (USAN);BHV 3500;SCHEMBL24131042;1337918-83-8;HY-134992;(R)-N-(3-(7-methyl-1H-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)piperazin-1-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide;Zavegepant [WHO-DD];Zevagepant;Vazegepant;zavegepantum;CS-0168642;BHV-3500;GTPL11513;DA-78843;1-Piperidinecarboxamide, 4-(1,2-dihydro-2-oxo-3-quinolinyl)-N-[(1R)-1-[(7-methyl-1H-indazol-5-yl)methyl]-2-[4-(1-methyl-4-piperidinyl)-1-piperazinyl]-2-oxoethyl]-;CHEBI:229643;BHV3500;SCHEMBL107428;BMS-742413;UNII-ODU3ZAZ94J;ZAVEGEPANT [INN];EX-A6698;WLZ3773;CHEMBL2397415;D11898;Vazegepant?;N-{(2R)-3-(7-methyl-1H-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl}-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide;BMS 742413;BMS742413;N-[(2R)-3-(7-methyl-1H-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-1H-quinolin-3-yl)piperidine-1-carboxamide |